Result Highlights
Soft 9M17 earnings
CTRA delivered a soft performance as 9M17 net profit declined by 8.4% YoY to IDR 566 bn, accounting for 65.54% of our revised projection and 54.6% of consensus’ estimates. We believe laggard 9M17 earnings were mainly caused by property sales margin contraction, slipping from 77% to 75%, in conjunction with a lower 9M17 net margin of 13.0% vs. 14.0% in 9M16. On a quarterly basis, CTRA posted higher 3Q17 net profit of IDR 227 bn (+84.3% YoY) on the back of lower opex (-39.6% YoY). Meanwhile, CTRA’s residential and shop-house sales declined slightly, by 5.5%, and apartment sales were hugely disappointing (-33.7% YoY). Revenue in 3Q17 alone only contributed IDR 1.5tn (-2.1% YoY), despite the company has not recognized land sales amounting to IDR 239 bn.
Net gearing increased due to higher interest-bearing debt
The Company held higher net debt level at IDR 3.96 tn with net gearing of 30.3% vs. IDR 3.56 tn of net debt and 27.7% of net gearing in 2Q17. The issuance of SGD 150 mn of Medium Term Notes in September 2017 has contributed to the rise of net debt level. The proceeds from the MTN will be used to refinance its current outstanding MTN of SGD 47 mn that will fall due in February 2018. Carrying a lower coupon rate (4.85% vs. 5.625%), we expect CTRA to record lower interest expenses in 2018 (down from IDR 642 bn in 2017 to IDR 597 bn in 2018). Despite the rencent increse in net gearing, CTRA still has among the lowest net gearing levels in the sector, third next to BSDE and PWON. Mean while, operating cash flow remained positive at IDR 334 bn, higher than IDR 18 bn reported in 9M16. Furthermore, Sales advances stood similar with 2Q17 figure at IDR 6.5 tn, which were still higher than IDR 5.8 tn recorded in 2Q16.
Marketing sales achievement falling short of target
In 3Q17, CTRA recorded marketing sales of IDR 2.3 tn which saw the 9M17 marketing sales to IDR 5.3 tn, up by 21.5% YoY. The launch in North Citraland has supported the marketing sales achievement in which generated IDR 1.1 tn. The 9M17 marketing sales run rate currently stands at 65.43% of our full year target of IDR 8.1 tn and 61.8% of the management’s target of IDR 8.5 tn. We identify there will be several major drivers to support marketing sales in 4Q17. First, CTRA have an agreement with The Ascott Limited to sell 192 serviced apartments in Ciputra World 2 Jakarta with total value of IDR 675 bn. CTRA expects the marketing sales to be recognized in November 2017. Secondly, CTRA plans to launch Newton 2 by early November 2017 at the latest. Thus far, take up rates are less than 60% of the total units offered (624 units). From the Newton launching, we expect CTRA to obtain additional marketing sales of IDR 450 bn.
Rating and Valuation
We reiterate our BUY recommendation but revised 12 month forward target price of IDR 1,480 to IDR 1,360. We downgraded our FY17/18F earnings by 21.31%/3.49% due to slower revenue recognition. Despite lower earnings forecast, we continue to like CTRA, as its diversified project portfolio and a decrease in revenue backlog could potentially help outperform peers when property market recovers. CTRA is currently valued at 21.4x FY18E P/E and 55.7% discount to RNAV.
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
